Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 251 - 300 out of 84,315

Document Document Title
WO/2014/196549A1
The present invention provides, for example, the following: a substrate for cell culture, which is a support on which are contained nanofibers formed from a biopolymer selected from the group consisting of gelatin, collagen, and cellulos...  
WO/2014/195554A1
The invention relates to a novel nucleotide sequence coding for an enzyme having dextransucrase activity, isolated from a bacterial strain of Lactobacillus sakei that can produce exopolysaccharide, more specifically from pork loin lunch ...  
WO/2014/197457A1
Pseudomonas chlororaphis NRRL B -30761 produces monorhamnolipids with predominantly 3-hydroxydodecenoyl-3-hydroxydecanoate (C12:1-C10) or 3-hydroxydodecanoyl-3-hydroxydecanoate (C12-C10) as the lipid moiety under static growth conditions...  
WO/2014/196675A1
The present invention relates to an absorptive microalgae dewatering apparatus and, more specifically, to an absorptive microalgae dewatering apparatus being characterized by: preventing the sagging and deformation of an absorption membe...  
WO/2014/197296A1
The present invention relates to xylanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the va...  
WO/2014/196775A1
The present invention relates to a novel Lactobacillus brevis G-101 strain capable of dissolving monosodium L-glutamate (MSG), and a functional health food, a pharmaceutical composition, or a food product containing the Lactobacillus G-1...  
WO/2014/195297A1
The invention relates to probiotic strains, compositions containing at least two probiotic strains and pharmaceutical agents containing at least one probiotic strain according to the invention or at least one composition according to the...  
WO/2014/192765A1
Provided is a control method capable of enhancing and/or suppressing the expression of a target gene in cyanobacteria. One mode of the control method for the expression of the target gene according to the present invention is a method fo...  
WO/2014/191205A1
The invention relates to a yeast strain of the type Yarrowia lipolytica, said strain being characterized by containing a phytoene synthase and a phytoene desaturase and by having a reduced activity of the proteins Pox1p, Pox2p, Pox3p, Po...  
WO/2014/193344A1
A system and method for managing an ethanologen for use in biorefinery is disclosed. The method for propagating ethanologen for use in the production of a fermentation product from biomass comprises the steps of providing a medium for pr...  
WO/2014/192647A1
Provided is an enzyme solution in which the saccharification rate is not prone to decrease in saccharification reactions that extend over a long period of time. Trichoderma fungal culture cells which express β-glucosidase derived from P...  
WO/2014/193473A1
This invention provides for recombinant anaerobic acetogenic bacterial cells having one or more nucleic acids whereby isoprene, mevalonate and/or other industrial bio-products are produced in a substantially oxygen-free culture condition...  
WO/2014/193052A1
The present invention relates to a corynebacterium including a polynucleotide for coding a psicose 3-epimerase enzyme, and a method for producing psicose by using the same, and more specifically, to: a corynebacterium including a polynuc...  
WO/2014/193014A1
The present invention relates to nano-sized kimchi lactic acid bacteria and, more specifically, to Lactobacillus plantarum lactic acid bacteria isolated from kimchi having an excellent effect of improving an intestinal environment. The n...  
WO/2014/191917A1
The present invention relates to a new non-toxigenic strain of Aspergillus flavus, that has been isolated in Italy and assigned to VCG IT6, and also to compositions comprising the same, and to the use thereof as a biocontrol agent agains...  
WO/2014/193164A1
The present invention relates to a microalgae transformation method comprising the step of mixing aminoclay, exogenous nucleic acids, and microalgae. The present invention also relates to a microalgae transformation composition comprisin...  
WO/2014/192919A1
A separation structure comprises the following: a tubular structure in which one end is closed to form a bottom part and the other end is open; and a cap that hermetically seals the opening. The structure is configured by at least two tu...  
WO/2014/194189A1
The present invention provides methods for the cultivation of the Methylobacterium genus of bacteria. In particular the method provides methods for the efficient and inexpensive cultivation of these bacteria. Additionally, the invention ...  
WO/2014/192905A1
The present invention relates to: fermented milk that does not undergo the increase in an acid level; a method for producing the fermented milk; Lactobacillus delbrueckii subsp. bulgaricus OLL1171 (NITE BP-01569) which is a lactic acid p...  
WO/2014/188721A1
Isolated IMP-3-derived epitope peptides having Th1 cell inducibility are disclosed herein. Such peptides can be recognized by MHC class II molecules and induce Th1 cells. In preferred embodiments, such a peptide of the present invention ...  
WO/2014/187269A1
Construction and fermentation of dimerized thrombopoietin (TPO) mimetic peptide (TMP) diad-human serum albumin (HSA) fusion protein. The fusion protein contains one HSA and two TPO mimetic peptides that are connected by means of a short ...  
WO/2014/188888A1
Provided is a culturing method capable of causing a three-dimensional aggregate in which cell function is similar to in vivo function to adhere to a culturing vessel while improving permeability of nutrients, oxygen, drugs and reagents f...  
WO/2014/188911A1
The present invention provides, as a cell carrier, a photodegradable crosslinking agent with which it is possible to produce a photodegradable gel with an appropriate water content, adequate water solubility, and sufficient strength to f...  
WO/2014/188994A1
Provided is a method for producing a functional cell from an undifferentiated organ cell with high efficiency and at low cost. A method for amplifying an undifferentiated liver cell, which comprises culturing the undifferentiated liver c...  
WO/2014/189127A1
 Provided are a new peptide, a vector incorporating a DNA that codes said peptide, a transformant obtained by transformation with that vector, and applications of said peptide, vector and transformant. The peptide according to the pr...  
WO/2014/187355A1
Provided are an Escherichia coli containing a mutated lpdA gene and an application thereof, and also provided are an application and a method for producing chemical materials such as ethanol and succinic acid by using the escherichia col...  
WO/2014/189469A1
The invention provides compositions comprising an alkene epoxidase and a selective epoxide hydrolase, such as a recombinant microorganism comprising a first heterologous nucleic acid encoding an alkene epoxidase and a second heterologous...  
WO/2014/189963A1
The present invention relates to microbial compositions useful in treating and remediating wastewater, removing organic matter from the surfaces of post harvested fruits and vegetables, and decreasing post-harvest disease in fruit and ve...  
WO/2014/190229A1
Provided herein are methods for preparing a microbiome sample for transplantation into a subject in need thereof. In particular, the methods and compositions relate to methods of repopulating the microbiome of a subject in the treatment ...  
WO/2014/189469A8
The invention provides compositions comprising an alkene epoxidase and a selective epoxide hydrolase, such as a recombinant microorganism comprising a first heterologous nucleic acid encoding an alkene epoxidase and a second heterologous...  
WO/2014/187151A1
The present invention discloses autolytic recombinant bacteria, a preparation method and an application thereof. The recombinant bacteria are prepared using a method comprising the following steps: introducing E7 lysis protein-encoding g...  
WO/2014/187357A1
Provided is an engineered recombinant Escherichia coli for producing succinic acid. The Escherichia coli comprises the following one or more modifications: a) enhancement of protein activity coded by a gene related to a pentose phosphate...  
WO/2014/185635A1
The present invention relates to recombinant yeast having high productivity of ethanol from xylose and, more specifically, to recombinant yeast having a high productivity of ethanol from xylose in which a gene encoding xylose reductase (...  
WO/2014/185439A1
In the present invention, by inactivating a CyHV-2 virus, a highly effective CyHV-2 infectious disease vaccine is obtained. Also by the present invention, a method is developed for continuous propagation of the CyHV-2 virus, which was co...  
WO/2014/184410A1
The invention relates to the Lactobacillus plantarum strain TC92, to mutants thereof, and to the use of said strain as a pesticide for controlling fire blight in plants of the Rosaceae family. Additional aspects of the invention relate t...  
WO/2014/183649A1
The present invention provides recombinant protein carrying an epitope. The recombinant protein has a skeleton structure from carrier protein, and a low immunogenic protein epitope is imported through splicing, replacement, and/or insert...  
WO/2014/185419A1
[Problem] To provide a new strain which can be used effectively and safely as a biological pesticide and which exhibits sufficient control activity against a plurality of types of harmful insects as well as exhibiting plant growth regula...  
WO/2014/185457A1
A vitrification-cryopreservation instrument for cells or tissues, said vitrification-cryopreservation implement having a vitrification-liquid absorber that has, on a metal support, in order of increasing distance from said metal support,...  
WO/2014/184577A1
The present Invention relates to a method for the deformation and/or fragmentation of a cell, spore or virus, the method comprising: (I) bringing a liquid sample containing the cell, spore or virus into contact with a first surface of a ...  
WO/2014/185430A1
 Provided is a method for manufacturing L-amino acid. L-amino acid is manufactured by culturing, in a medium, coryneform bacteria having L-amino acid production capability modified so as to increase the phosphate transporter activity, ...  
WO/2014/183548A1
The present invention provides EV71 virus-like particles and a preparation method and application thereof. The method comprises: connecting a P1 protein gene and 3CD protease gene of an EV71 virus with PMV plasmid to construct PMV-P1-3CD...  
WO/2014/185798A1
The method of modification of natural strains of Saccharomyces sp., especially Saccharomyces cerevisiae and Saccharomyces boulardii, derived from different environments. The invention also includes a modified yeast strain and the method ...  
WO/2014/184492A1
The invention relates to a lyophilisate or to a powder including i) at least one globin, a globin protomer or an extracellular hemoglobin from annelids, and ii) at least one biological material from annelids that is different from said g...  
WO/2014/182054A1
The present invention relates to a recombinant microorganism metabolizing 3,6-anhydride-L-galactose and a use thereof, and, more specifically, can produce ethanol from a recombinant microorganism expressing an enzyme group involved in a ...  
WO/2014/183050A1
The present invention features methods for treating or reducing the severity of a microbial infection in an infant of a lactating mother. Compositions comprising food products fermented by Lactobacillus paracasei CBA L74, International D...  
WO/2014/180820A3
Yeast cell that is genetically modified comprising: a) a deletion or disruption of one or more nucleotide sequence selected from the group of GPD1, GPD2, GPP1 and GPP2 and b) presence of one or more heterologous nucleotide sequence encod...  
WO/2014/181786A1
The purpose of the present invention is to provide a versatile and effective method for promoting the crystallization of a protein of interest in X-ray crystal structure analysis. The abovementioned problem can be solved by (1) a polypep...  
WO/2014/182125A1
The present invention relates to a novel isolated polypeptide having the ability to export O-phosphoserine (OPS) that is a precursor of L-cysteine, a vector comprising the polynucleotide, an OPS-producing microorganism having enhanced ac...  
WO/2014/182016A1
The present invention relates to a method for preparing a recombinant microorganism simultaneously comprising genes encoding enzymes used for a biosynthesis pathway of 6-aminocaproic acid which is a precursor of caprolactam, biosynthesiz...  
WO/2014/180820A2
Yeast cell that is genetically modified comprising: a) a deletion or disruption of one or more nucleotide sequence selected from the group of GPD1, GPD2, GPP1and GPP2 and b) presence of one or more heterologous nucleotide sequence encodi...  

Matches 251 - 300 out of 84,315